Project Details
Description
We are developing a rapid, high throughput genetic test to simultaneously assess all known oncogenes and tumor suppressors in Cutaneous T Cell Lymphoma. This test will be useful for diagnosis and staging of patients and should pave the way for tailoring therapeutic strategies for each patient based on molecular data.
Status | Finished |
---|---|
Effective start/end date | 3/1/16 → 6/28/17 |
Funding
- Skin Cancer Foundation (Agreement 1/5/16)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.